Related Experiment Videos
Long term efficacy of a pen injector
S F Dinneen1, C C Cronin, D J O'Sullivan
1Department of Medicine, Cork Regional Hospital, Wilton.
Irish Journal of Medical Science
|September 1, 1991
Summary
Novopen insulin delivery showed high patient satisfaction but led to a significant worsening of blood sugar control (HbA1c). Long-term Novopen use may result in sub-optimal metabolic outcomes.
Area of Science:
- Endocrinology
- Diabetes Management
Background:
- Insulin administration devices are crucial for diabetes self-management.
- Novopen offers a pen-based insulin delivery system.
Purpose of the Study:
- To evaluate the long-term efficacy of Novopen for insulin administration.
- To assess metabolic control and patient satisfaction with Novopen therapy.
Main Methods:
- Retrospective analysis of 42 patients treated with Novopen between 1986 and 1988.
- Monitoring of HbA1c levels, weight, and insulin dosage.
- Patient-reported outcomes on ease of use and lifestyle flexibility.
Main Results:
- Mean HbA1c increased by 14.1% (p < 0.001), indicating statistically significant worsening of glycemic control.
- No significant changes in weight or insulin dose were observed.
- High patient satisfaction reported for ease of administration (81%) and lifestyle flexibility (95%).
Conclusions:
- Despite high patient satisfaction and perceived ease of use, long-term Novopen therapy is associated with sub-optimal metabolic control.
- The study highlights a potential trade-off between patient convenience and glycemic efficacy.
- Further research is needed to optimize pen-based insulin delivery systems for long-term diabetes management.